GSDMA and neoplasm: Emerging evidence demonstrated that pyroptosis, a programmed cell death (PCD) process mediated by gasdermin (GSDM), was a new bridge to tumor immunity, which could influence sensitivity to immunotherapy and chemotherapy [50, 51].